Juan Pablo Vinicki, Alejandra Cusa, Daniela Domingo, José Luis Velasco Zamora, Sebastián Magri, Alejandro Brigante, Maria Marcela Schmid, Paola Ávila, Natalia Zamora, Laura Sorrentino, Anabella M Rodriguez, Miguel Linarez, Cecilia Pisoni, Carolina Costi, Gustavo Rodriguez Gil, María Andrea Spinetto, Vanesa Ursula Paris, Natalia Perrotta, María Del Rosario Maliandi, Oscar Rillo, Claudia Pena, Julio Got, Javier Cavallasca, Maximiliano Machado Escobar, Carolina Iturralde, María Victoria Martire, Romina Tessel, N Saravia Chocobar, Graciela Alarcon
OBJECTIVES: The need for glucocorticoid-sparing drugs (GCSD) remains an important issue and is an unmet need in the treatment of polymyalgia rheumatica (PMR). We therefore aimed to assess the effectiveness and safety of methotrexate (MTX) and of leflunomide (LEF) in daily clinical practice in PMR patients from Argentina. METHODS: A multicentre and observational study (medical records review) of PMR patients seen between 2007 and 2023, who had at least three months of follow-up after starting a GCSD, either MTX or LEF, was performed...
2024: Rheumatology Advances in Practice